Skip to main content
Home

Language & Country Selector for Desktop

language-selector-globe Egypt | en

Choose Location

  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
  • Argentina | es
  • Brazil | pt
  • Canada | en
  • Canada | fr
  • Central America | es
  • Colombia | es
  • Mexico | es
  • United States | en
  • Venezuela | es
  • Australia | en
  • Bangladesh | en
  • Hong Kong S.A.R. | zh
  • India | en
  • Indonesia | en
  • Japan | ja
  • Korea | ko
  • Mainland China | zh
  • Malaysia | en
  • Pakistan | en
  • Philippines | en
  • Singapore | en
  • Taiwan | zh
  • Austria | de
  • Belgium | fr
  • Belgium | nl
  • Bulgaria | bg
  • Czech Republic | cs
  • Czech Republic | en
  • Denmark | da
  • Estonia | et
  • Finland | fi
  • France | fr
  • Germany | de
  • Greece | el
  • Hungary | hu
  • Ireland | en
  • Italy | it
  • Latvia | lv
  • Lithuania | lt
  • Netherlands | nl
  • Norway | no
  • Poland | pl
  • Portugal | pt
  • Romania | ro
  • Russia | ru
  • Serbia | sr
  • Slovakia | sk
  • Spain | es
  • Sweden | sv
  • Switzerland | de
  • Switzerland | fr
  • United Kingdom | en
  • Global | en
  • Sandoz | en
  • Novartis Foundation | en
  • Egypt | en
  • Israel | he
  • South Africa | en
  • Turkey | tr

Language & Country Selector for Mobile

language-selector-globe Egypt

Choose Location

Americas Asia Pacific Europe International Middle East & Africa
  • Argentina | es
  • Australia | en
  • Austria | de
  • Bangladesh | en
  • Belgium | fr
  • Belgium | nl
  • Brazil | pt
  • Bulgaria | bg
  • Canada | en
  • Canada | fr
  • Central America | es
  • Colombia | es
  • Czech Republic | cs
  • Czech Republic | en
  • Denmark | da
  • Egypt | en
  • Estonia | et
  • Finland | fi
  • France | fr
  • Germany | de
  • Greece | el
  • Hong Kong S.A.R. | zh
  • Hungary | hu
  • India | en
  • Indonesia | en
  • Ireland | en
  • Israel | he
  • Italy | it
  • Japan | ja
  • Korea | ko
  • Latvia | lv
  • Lithuania | lt
  • Mainland China | zh
  • Malaysia | en
  • Mexico | es
  • Netherlands | nl
  • Norway | no
  • Global | en
  • Sandoz | en
  • Novartis Foundation | en
  • Pakistan | en
  • Philippines | en
  • Poland | pl
  • Portugal | pt
  • Romania | ro
  • Russia | ru
  • Serbia | sr
  • Singapore | en
  • Slovakia | sk
  • South Africa | en
  • Spain | es
  • Sweden | sv
  • Switzerland | de
  • Switzerland | fr
  • Taiwan | zh
  • Turkey | tr
  • United Kingdom | en
  • United States | en
  • Venezuela | es
    • About 
      • Novartis in Egypt 
      • Strategy 
      • Diversity and Inclusion 
      • People and Culture 
      • Innovative Medicines 
      • Products 
      • Country Leadership Team 
        • Sherif Amin 
      A girl with a flower About
    • Patients and Caregivers 
      • Novartis Commitment to Patients and Caregivers 
      • Diseases 
      • Products 
      • Adverse Event Reporting 
      • Patient Partner Panel 
      A couple holding hands Patients and Caregivers
    • Healthcare Professionals 
      • Products 
      • Novartis Pipeline 
      • Adverse Event Reporting 
      • Novartis Clinical Trials 
      • Information for Physicians 
      Healthcare Professional Healthcare Professionals
    • ESG 
      • Ethical Behavior 
        • Code of Ethics 
        • SpeakUp 
      • Ethics, Risk and Compliance 
      • Access 
      • Environmental Sustainability 
      • Global Health 
      ESG ESG
    • News 
      • News Archive 
      • Media Releases 
      • Featured News 
      News News
    • Careers 
      • Career Search 
      • Meet the teams 
      • Personal Growth 
      • Early Talent 
      • How We Work 
      • Well-being 
      • Diversity and Inclusion 
      • Awards and Recognition 
      Careers Careers
    • Coronavirus 
      covid 10 grey image_0 COVID-19 Information Center
    • Contacts 
    Homepage Novartis in Egypt Home
  1. Home
  2. News
  3. News Archive
News Archive Navigation
  • All
  • Media Release
  • Featured News
icon
News Archive Navigation Language
  • English
  • French
  • German

April 2020

  • Media ReleaseApr 29, 2020
    Novartis Egypt announces wide-ranging initiatives to respond to COVID-19 Pandemic; Supports national efforts to fight COVID-19, awareness initiatives and commits to securing its drug supply
    Cairo, April 21, 2020 — As global efforts to protect and prevent against the spread of COVID-19 intensify, Novartis Egypt, including all its divisions: Pharma, Oncology, Sandoz and Technical…

October 2019

  • Media ReleaseOct 04, 2019
    Novartis Egypt Collaborates with Ministry of Health to Promote 100 Million Seha Initiative
    Cairo, 4 October 2019 – Novartis Pharma S.A.E (Novartis Egypt) organized an educational forum for healthcare practitioners as part of its efforts to support the Egyptian Ministry of Health (MoH)’s…
  • Media ReleaseOct 04, 2019
    نوفارتس مصر تتعاون مع وزارة الصحة من اجل دعم مبادرة ١٠٠ مليون صحة
    القاهرة، ٤ أكتوبر ٢٠١٩ - في إطار تعاونها الوثيق مع وزارة الصحة المصرية، نظمت شركة نوفارتس فارما ش.م.م. (نوفارتس مصر) ندوة تثقيفية لمقدمي خدمات الرعاية الصحية وذلك في سياق دعم مبادرة الرعاية الصحية…

October 2018

  • Media ReleaseOct 25, 2018
    Sharm Derma Conference in collaboration with Novartis Pharma S.A.E. promotes better understanding of Psoriasis
    ​Psoriasis a common, non-contagious, autoimmune disease affects about one adult in 50 worldwide1 Many people suffer needlessly from psoriasis due to incorrect or delayed diagnosis, inadequate…
  • Media ReleaseOct 18, 2018
    3rd MENA Headache Conference highlights migraine challenge and need for better treatment options
    In collaboration with the Headache Chapter of the Egyptian Society of Neurology, Psychiatry and Neurosurgery, Novartis launches “Migraine is not just a Headache” campaign in Egypt Migraine affects…

July 2018

  • Media ReleaseJul 31, 2018
    Novartis Pharma S.A.E confirms all company products in Egypt unaffected by valsartan recall
    Cairo, July 31, 2018 – Novartis Pharma S.A.E (Novartis Pharma) confirms that none of its products in Egypt are affected by the decision to recall certain products containing valsartan All Novartis…

May 2018

  • Media ReleaseMay 06, 2018
    Novartis Egypt celebrates its 22nd annual community partnership day alongside more than 23,000 associates worldwide with a massive blood donation campaign
    In Egypt, associates from Novartis Egypt (Novartis Pharma S.A.E and its divisions: Oncology, Sandoz Egypt and Alcon) are giving back to their communities through a widespread Social Responsibility…

March 2018

  • Media ReleaseMar 01, 2018
    “I Love Life” Showcased During CardioEgypt 2018’s Proceedings
    1 in 5 people over the age of 40 will develop Heart Failure in their lifetime1 Sacubitril/valsartan Shows 20% Reduction in Risk of Cardiovascular Death Giving New Hope to Those Living with Heart…

November 2017

  • Media ReleaseNov 24, 2017
    New Hope for Organ Transplant Patients in Egypt
    Novartis TRANSFORM confirms strong efficacy of EVEROLIMUS-based regimen with lower exposure to nephrotoxic calcineurin inhibitor (CNI)1 The Novartis study is the largest de novo interventional study…

October 2017

  • Media ReleaseOct 13, 2017
    "LOVE LIVE" - Healthcare organizations mark the launch of nationwide heart failure awareness campaign
    Study reveals Egyptian heart failure patients affected by the disease at an average age of 57, nearly 10-13 years younger than their European counterparts1 Cairo, 13 October, 2017 - The Magdi Yacoub…

To report an adverse event or any drug related issues concerning Novartis medicinal products; please contact Novartis Patient Safety: Tel: +202 22861000 - Press 3 for reporting an adverse event. Fax: 002 02 26031702. E-mail: [email protected]

للإبلاغ عن أثر جانبى أو أي مشكلة دوائية متعلقة بمنتجات نوفارتس الطبية او الاجهزة ؛ يرجى الاتصال بقسم اليقظة الدوائية في شركة نوفارتس
[email protected] البريد الإلكترونى
 +202 22861000 : الهاتف
ثم اضغط 3 للإبلاغ عن أثر جانبي او الخط الأرضى 20224524036+

 +2 02 26031702 : الفاكس

Novartis Egypt

Navigate Novartis
  • Patients & Caregivers
  • Healthcare Professionals
  • ESG
  • News
  • Careers
Media Center
  • News Archive
Our Portfolio
  • Novartis Clinical Pipeline
  • Novartis Product Portfolio
Other Novartis websites
  • Global site
Footer Bottom
© 2023 Novartis AG
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
This site is intended for an audience in Egypt.